19-14515954-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_006145.3(DNAJB1):c.1009G>T(p.Val337Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000405 in 1,608,236 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006145.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAJB1 | NM_006145.3 | c.1009G>T | p.Val337Phe | missense_variant | 3/3 | ENST00000254322.3 | NP_006136.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAJB1 | ENST00000254322.3 | c.1009G>T | p.Val337Phe | missense_variant | 3/3 | 1 | NM_006145.3 | ENSP00000254322 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000342 AC: 52AN: 151914Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000490 AC: 121AN: 247038Hom.: 1 AF XY: 0.000448 AC XY: 60AN XY: 134002
GnomAD4 exome AF: 0.000412 AC: 600AN: 1456202Hom.: 2 Cov.: 31 AF XY: 0.000410 AC XY: 297AN XY: 724860
GnomAD4 genome AF: 0.000342 AC: 52AN: 152034Hom.: 1 Cov.: 32 AF XY: 0.000444 AC XY: 33AN XY: 74330
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 29, 2022 | The c.1009G>T (p.V337F) alteration is located in exon 3 (coding exon 3) of the DNAJB1 gene. This alteration results from a G to T substitution at nucleotide position 1009, causing the valine (V) at amino acid position 337 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at